These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 11251981)

  • 1. Quantification of tumor cell injury in vitro and in vivo using expression of green fluorescent protein under the control of the GADD153 promoter.
    Lin X; Gately DP; Hom D; Mishima M; Los G; Howell SB
    Int J Cancer; 2001 Feb; 91(4):555-62. PubMed ID: 11251981
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quantitation of the change in GADD153 messenger RNA level as a molecular marker of tumor response in head and neck cancer.
    Los G; Benbatoul K; Gately DP; Barton R; Christen R; Robbins KT; Vicario D; Kirmani S; Orloff LA; Weisman R; Howell SB
    Clin Cancer Res; 1999 Jul; 5(7):1610-8. PubMed ID: 10430059
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cisplatin and taxol activate different signal pathways regulating cellular injury-induced expression of GADD153.
    Gately DP; Sharma A; Christen RD; Howell SB
    Br J Cancer; 1996 Jan; 73(1):18-23. PubMed ID: 8554977
    [TBL] [Abstract][Full Text] [Related]  

  • 4. DNA damage inducible-gene expression following platinum treatment in human ovarian carcinoma cell lines.
    Delmastro DA; Li J; Vaisman A; Solle M; Chaney SG
    Cancer Chemother Pharmacol; 1997; 39(3):245-53. PubMed ID: 8996528
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Induction of the growth arrest and DNA damage-inducible gene GADD153 by cisplatin in vitro and in vivo.
    Gately DP; Jones JA; Christen R; Barton RM; Los G; Howell SB
    Br J Cancer; 1994 Dec; 70(6):1102-6. PubMed ID: 7981060
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of GADD153 in tumor cells and stromal cells from xenografted tumors in nude mice treated with cisplatin: correlations with cisplatin-DNA adducts.
    Johnsson A; Strand C; Los G
    Cancer Chemother Pharmacol; 1999; 43(4):348-52. PubMed ID: 10071988
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Abrogation of p53 function affects gadd gene responses to DNA base-damaging agents and starvation.
    Zhan Q; Fan S; Smith ML; Bae I; Yu K; Alamo I; O'Connor PM; Fornace AJ
    DNA Cell Biol; 1996 Oct; 15(10):805-15. PubMed ID: 8892753
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression and transactivating functions of the bZIP transcription factor GADD153 in mammary epithelial cells.
    Talukder AH; Wang RA; Kumar R
    Oncogene; 2002 Jun; 21(27):4289-300. PubMed ID: 12082616
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Selection of drugs to test the specificity of the Tg.AC assay by screening for induction of the gadd153 promoter in vitro.
    Thompson KL; Sistare FD
    Toxicol Sci; 2003 Aug; 74(2):260-70. PubMed ID: 12730611
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Robust prostate-specific expression for targeted gene therapy based on the human kallikrein 2 promoter.
    Xie X; Zhao X; Liu Y; Young CY; Tindall DJ; Slawin KM; Spencer DM
    Hum Gene Ther; 2001 Mar; 12(5):549-61. PubMed ID: 11268287
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Upregulation of GADD153 expression in the apoptotic signaling of N-(4-hydroxyphenyl)retinamide (4HPR).
    Xia Y; Wong NS; Fong WF; Tideman H
    Int J Cancer; 2002 Nov; 102(1):7-14. PubMed ID: 12353227
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nuclear factor 1 is a negative regulator of gadd153 gene expression in vascular smooth muscle cells.
    Nakamura M; Okura T; Kitami Y; Hiwada K
    Hypertension; 2001 Feb; 37(2 Pt 2):419-24. PubMed ID: 11230311
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro and in vivo characterization of a dual-function green fluorescent protein--HSV1-thymidine kinase reporter gene driven by the human elongation factor 1 alpha promoter.
    Luker GD; Luker KE; Sharma V; Pica CM; Dahlheimer JL; Ocheskey JA; Fahrner TJ; Milbrandt J; Piwnica-Worms D
    Mol Imaging; 2002; 1(2):65-73. PubMed ID: 12920846
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nicotine affects the signaling of the death pathway, reducing the response of head and neck cancer cell lines to DNA damaging agents.
    Onoda N; Nehmi A; Weiner D; Mujumdar S; Christen R; Los G
    Head Neck; 2001 Oct; 23(10):860-70. PubMed ID: 11592233
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Activation of the gadd153 promoter by genotoxic agents: a rapid and specific response to DNA damage.
    Luethy JD; Holbrook NJ
    Cancer Res; 1992 Jan; 52(1):5-10. PubMed ID: 1727386
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Activation of peroxisome proliferator-activated receptor-gamma stimulates the growth arrest and DNA-damage inducible 153 gene in non-small cell lung carcinoma cells.
    Satoh T; Toyoda M; Hoshino H; Monden T; Yamada M; Shimizu H; Miyamoto K; Mori M
    Oncogene; 2002 Mar; 21(14):2171-80. PubMed ID: 11948400
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Induction of the mammalian stress response gene GADD153 by oxidative stress: role of AP-1 element.
    Guyton KZ; Xu Q; Holbrook NJ
    Biochem J; 1996 Mar; 314 ( Pt 2)(Pt 2):547-54. PubMed ID: 8670069
    [TBL] [Abstract][Full Text] [Related]  

  • 18. GADD153-mediated anticancer effects of N-(4-hydroxyphenyl)retinamide on human hepatoma cells.
    Kim DG; You KR; Liu MJ; Choi YK; Won YS
    J Biol Chem; 2002 Oct; 277(41):38930-8. PubMed ID: 12138118
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adenovirus-mediated heat-activated antisense Ku70 expression radiosensitizes tumor cells in vitro and in vivo.
    Li GC; He F; Shao X; Urano M; Shen L; Kim D; Borrelli M; Leibel SA; Gutin PH; Ling CC
    Cancer Res; 2003 Jun; 63(12):3268-74. PubMed ID: 12810658
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular analysis of p21 promoter activity isolated from squamous carcinoma cell lines of the head and neck under the influence of 1,25(OH)2 vitamin D3 and its analogs.
    Hager G; Kornfehl J; Knerer B; Weigel G; Formanek M
    Acta Otolaryngol; 2004 Jan; 124(1):90-6. PubMed ID: 14977084
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.